TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Disease Control Rate (DCR) at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Length of the tumour feeding artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Feedback from Community Advisory Board
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neuromuscular function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor performance assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in gingival depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in keratinized tissue thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in root coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limb spasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anastomotic Leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With Changes Across Transcript Profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Global percentage of pigment clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Number of Months of Progression-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Participants With Grade 3 or Higher Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Histological change in nerve density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Histological change in nerve morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pressure waveform
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Back Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Eating Index 2010
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PNNS-GS diet score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sCD62L levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: SPARC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Association of food items/groups with anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post-operative hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in mean scores on FACIT-Pal Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Retention of autologous fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of eating disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritable Bowel Syndrome Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stimulation of the wound's edges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients with post-therapeutic FDG uptake consistent with diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in CD8+ T-cell Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Sexual Activity in the Past Three Months
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in Condom and Birth Control Use during Sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pregnancy Occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of subjects adherent/persistent (6 weeks)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of subjects adherent/persistent (12 weeks)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Ora Calibra Ocular Discomfort Scale (ODS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity for detecting HCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gym attendance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Heme and Non-Heme Iron Absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heme and Non-Heme Transfer to Fetus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of headache frequency/intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adipocyte Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood Pressure (BP) Readings: Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intimate Partner Aggression
Endpoint domain: Adverse events/effects
Primary endpoint: Number of new locations replicated
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: change in pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Average AM/PM Nasal Congestion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in logMAR Contact Lens Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants in the Test Lens Group Agreeing With the Statement Are Comfortable Throughout the Day
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants in the Test Lens Group Agreeing With the Statement Provide Clear Vision Throughout the Day
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EE Activity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiomics features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent reduction in low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: E.Coli Bacteriuria Plus Pyuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in size of fibroadenomata
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Foot morphology variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documentation of end-of-life preferences
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: IOP-lowering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving confirmed MR4.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of temsirolimus
Endpoint domain: Adverse events/effects
Primary endpoint: Motor Optimality Score (MOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Prevalence of osteoporosis related fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Infusional toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of cancers
Endpoint domain: Adverse events/effects
Primary endpoint: Electronically measured adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cannabis Use Frequency Over Time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Point Prevalence Abstinence Over the Three Post-quit Attempt Assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-reported Sleep Quality Over Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Objective Sleep Quality Over Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: CHA2-DS2-VASc Score at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HAS-BLED Score at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Who Died (Treatment-Related) During First 6 Months of Treatment
Endpoint domain: Mortality/survival
Primary endpoint: Compliance with milk consumption
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bleeding Cessation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in word reading speed and accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in trained letter-sound correspondences accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Granzyme A serum levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of glucose values within target range (100-140)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Intra-vaginal Ejaculation Latency Time (IELT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change of score of Premature ejaculation diagnostic tool (PEDT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change of grade Premature ejaculation profile (PEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: 3-year Disease Free Survival (DFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: Skeletal muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Durations of ICU and hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of patients with abnormal glomerular filtration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bone marrow fat content at lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of CD8+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of children with developmental delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach program goals
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Number of subjects diagnosed with CIN2+ cervical lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Uncorrected Visual Acuity Across a Range of Distances at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Best Corrected Visual Acuity (BCVA) Across a Range of Distances at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of Subjects That Achieved Spherical Equivalent Within ± 0.5D, ± 0.75D, and ± 1.0D at Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incident Cardiovascular Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total Blood Loss Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Foot-related functional status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Lung cancer death
Endpoint domain: Mortality/survival
Primary endpoint: Gagging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropsychological changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain Anxiety Symptom Scale Rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Challenge outcome according to PRACTALL-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response (OR) Post Transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-Related Mortality (TRM)
Endpoint domain: Mortality/survival
Primary endpoint: Normalization of LV diastolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of parturients needing more analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor response for non-irradiated brain lesions at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality of Life and overall health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of Insulin-independent Subjects With Full Islet Graft Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean defect quality estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting total cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Migraine-Specific Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Enjoyment & Satisfaction Questionnaire-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HbA1c change post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in ETDRS Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy in inflating the cuff of the endotracheal tubes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival to liver transplantation
Endpoint domain: Mortality/survival
Primary endpoint: FeNO Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FeNO Categorical Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Acute graft-versus-host disease (aGVHD) II-IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Chronic graft-versus-host disease (GvHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean spherical error (MSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of imaging techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Acute Inflammatory Histologic Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in 24-hour urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinician Administered PTSD Scale (CAPS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of Violence Against Women Scale (SVAWS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional capacity of CD4+, CD25+, CD127- T-regulatory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BOLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Global Health Status/QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in stone surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Autograft Take
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of infusions associated with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants showing no evidence of disease progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal endoscopic findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive Omeprazole tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in DASH Survey scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cumulative post-operative pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful Self-Injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sun Burning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Concentration of Epinephrine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postprandial Hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Expectations and needs for home support
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Healthcare professionals' knowledge and understanding of safety messages
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Correlation of clinical outcomes with PET scan metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Difference in Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Progress-Free Survival at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: rate of haemorrhagic complications
Endpoint domain: Adverse events/effects
Primary endpoint: rate of thromboembolic complications
Endpoint domain: Adverse events/effects
Primary endpoint: Sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alterations in quantitative and qualitative bone in the foot
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional ambulatory category
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of sense of competence in dementia care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in agitation and aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Not Experiencing a System or Procedure Related Complication
Endpoint domain: Adverse events/effects
Primary endpoint: Corneal densitometry scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tibialis Anterior muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Frequency of ACS Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: biodistribution of [18F]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumoural uptake of [18F]-FET-βAG-TOCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in clinical critical treatment index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Child BMI Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rates of intestinal atresias and limb abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rates of preterm labor, fetal growth restriction and spontaneous abortions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Rates of maternal SARS-CoV-2 infection among mothers to infants born with intestinal atresias or limb anomalies
Endpoint domain: Adverse events/effects
Primary endpoint: Complication rate (stent migration and tumor ingrowth)
Endpoint domain: Adverse events/effects
Primary endpoint: Median percent change in levels of serum β CTX (sCTX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean percent change from baseline in intra-tumoral kPL within target lesion after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean percent change from baseline in intra-tumoral kPG within target lesion after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in arm and hand function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With MI Skillfulness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alignment of intraocular lens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Composite score on total Hip or Knee Prosthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacteria change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes